Placing Patients At The Center Of Drug Design

Source: Catalent

Patient centricity has always been at the heart of the pharmaceutical industry. With rising costs of drugs and healthcare, there has been an increased focus on the topic. Poor patient acceptance and adherence to medications continue to be some of the top challenges facing the healthcare and pharmaceutical industries. Although the reasons for non-adherence are multifactorial, drug developers can bring patient insights into the design of their drug products to potentially improve patient acceptance and adherence.

Experts from Catalent discuss the best time to start thinking about patient centricity during development, the steps developers can take to achieve patient-centric drug design, and how formulation and dosage forms can make a difference for patients.

access the Q&A!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.

Subscribe to Life Science Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Life Science Leader